Subject(s)

Cystic Fibrosis Transmembrane Conductance Regulator , Cystic Fibrosis , Adult , Aminophenols , Chloride Channel Agonists/therapeutic use , Cystic Fibrosis Transmembrane Conductance Regulator/genetics , Humans , Mutation , Quality of Life